nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—NR3C2—Betamethasone—hematologic cancer	0.0602	0.136	CbGbCtD
Eplerenone—NR3C2—Prednisolone—hematologic cancer	0.0594	0.134	CbGbCtD
Eplerenone—NR3C2—Dexamethasone—hematologic cancer	0.035	0.079	CbGbCtD
Eplerenone—Hydrocortamate—Prednisone—hematologic cancer	0.0188	0.0538	CrCrCtD
Eplerenone—Hydrocortamate—Prednisolone—hematologic cancer	0.0184	0.0525	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—hematologic cancer	0.0182	0.0521	CrCrCtD
Eplerenone—Cortisone acetate—Prednisolone—hematologic cancer	0.0178	0.0509	CrCrCtD
Eplerenone—Fluoxymesterone—Betamethasone—hematologic cancer	0.0175	0.0501	CrCrCtD
Eplerenone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.0175	0.0501	CrCrCtD
Eplerenone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.0171	0.049	CrCrCtD
Eplerenone—Fludrocortisone—Dexamethasone—hematologic cancer	0.0171	0.0488	CrCrCtD
Eplerenone—Fludrocortisone—Betamethasone—hematologic cancer	0.0171	0.0488	CrCrCtD
Eplerenone—Fludrocortisone—Triamcinolone—hematologic cancer	0.0167	0.0477	CrCrCtD
Eplerenone—Fluoxymesterone—Prednisolone—hematologic cancer	0.0159	0.0454	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—hematologic cancer	0.0158	0.0453	CrCrCtD
Eplerenone—Progesterone—Prednisolone—hematologic cancer	0.0155	0.0442	CrCrCtD
Eplerenone—Fludrocortisone—Prednisolone—hematologic cancer	0.0155	0.0442	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—hematologic cancer	0.0154	0.0441	CrCrCtD
Eplerenone—Methyltestosterone—Prednisolone—hematologic cancer	0.0151	0.0431	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.014	0.0316	CbGbCtD
Eplerenone—CYP3A7—Ifosfamide—hematologic cancer	0.014	0.0316	CbGbCtD
Eplerenone—Hydrocortisone—Dexamethasone—hematologic cancer	0.0139	0.0398	CrCrCtD
Eplerenone—Hydrocortisone—Betamethasone—hematologic cancer	0.0139	0.0398	CrCrCtD
Eplerenone—Hydrocortisone—Triamcinolone—hematologic cancer	0.0136	0.0389	CrCrCtD
Eplerenone—Testosterone—Prednisolone—hematologic cancer	0.0134	0.0384	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0134	0.0302	CbGbCtD
Eplerenone—CYP3A7—Imatinib—hematologic cancer	0.0134	0.0302	CbGbCtD
Eplerenone—CYP3A5—Daunorubicin—hematologic cancer	0.0131	0.0296	CbGbCtD
Eplerenone—Hydrocortisone—Prednisone—hematologic cancer	0.0129	0.0369	CrCrCtD
Eplerenone—Hydrocortisone—Prednisolone—hematologic cancer	0.0126	0.036	CrCrCtD
Eplerenone—CYP3A5—Thalidomide—hematologic cancer	0.012	0.027	CbGbCtD
Eplerenone—CYP3A5—Teniposide—hematologic cancer	0.0114	0.0257	CbGbCtD
Eplerenone—CYP3A5—Ifosfamide—hematologic cancer	0.0105	0.0237	CbGbCtD
Eplerenone—CYP3A5—Imatinib—hematologic cancer	0.0101	0.0227	CbGbCtD
Eplerenone—CYP3A4—Bexarotene—hematologic cancer	0.00873	0.0197	CbGbCtD
Eplerenone—CYP3A7—Irinotecan—hematologic cancer	0.00837	0.0189	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00837	0.0189	CbGbCtD
Eplerenone—CYP3A4—Busulfan—hematologic cancer	0.00811	0.0183	CbGbCtD
Eplerenone—CYP3A4—Lomustine—hematologic cancer	0.00811	0.0183	CbGbCtD
Eplerenone—CYP3A5—Dasatinib—hematologic cancer	0.00807	0.0182	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00732	0.0165	CbGbCtD
Eplerenone—CYP3A7—Vincristine—hematologic cancer	0.00732	0.0165	CbGbCtD
Eplerenone—CYP3A4—Thiotepa—hematologic cancer	0.00723	0.0163	CbGbCtD
Eplerenone—CYP3A5—Irinotecan—hematologic cancer	0.00628	0.0142	CbGbCtD
Eplerenone—CYP3A4—Methoxsalen—hematologic cancer	0.00562	0.0127	CbGbCtD
Eplerenone—CYP3A7—Dexamethasone—hematologic cancer	0.00551	0.0124	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00551	0.0124	CbGbCtD
Eplerenone—CYP3A5—Vincristine—hematologic cancer	0.00549	0.0124	CbGbCtD
Eplerenone—CYP3A4—Bortezomib—hematologic cancer	0.00535	0.0121	CbGbCtD
Eplerenone—CYP3A4—Daunorubicin—hematologic cancer	0.00512	0.0115	CbGbCtD
Eplerenone—CYP3A5—Etoposide—hematologic cancer	0.00503	0.0113	CbGbCtD
Eplerenone—CYP3A4—Cytarabine—hematologic cancer	0.00451	0.0102	CbGbCtD
Eplerenone—CYP3A4—Teniposide—hematologic cancer	0.00445	0.01	CbGbCtD
Eplerenone—CYP3A5—Dexamethasone—hematologic cancer	0.00413	0.00933	CbGbCtD
Eplerenone—CYP3A4—Ifosfamide—hematologic cancer	0.0041	0.00926	CbGbCtD
Eplerenone—CYP3A4—Imatinib—hematologic cancer	0.00392	0.00884	CbGbCtD
Eplerenone—CYP3A4—Ruxolitinib—hematologic cancer	0.00369	0.00833	CbGbCtD
Eplerenone—CYP3A4—Nilotinib—hematologic cancer	0.00356	0.00804	CbGbCtD
Eplerenone—CYP3A4—Vinorelbine—hematologic cancer	0.00353	0.00797	CbGbCtD
Eplerenone—CYP3A4—Triamcinolone—hematologic cancer	0.00323	0.00729	CbGbCtD
Eplerenone—CYP3A4—Dasatinib—hematologic cancer	0.00315	0.0071	CbGbCtD
Eplerenone—CYP3A4—Mitoxantrone—hematologic cancer	0.00311	0.00702	CbGbCtD
Eplerenone—CYP3A4—Betamethasone—hematologic cancer	0.00277	0.00625	CbGbCtD
Eplerenone—CYP3A4—Prednisolone—hematologic cancer	0.00273	0.00617	CbGbCtD
Eplerenone—CYP3A4—Prednisone—hematologic cancer	0.00258	0.00583	CbGbCtD
Eplerenone—CYP3A4—Irinotecan—hematologic cancer	0.00245	0.00552	CbGbCtD
Eplerenone—CYP3A4—Vinblastine—hematologic cancer	0.00218	0.00491	CbGbCtD
Eplerenone—CYP3A4—Vincristine—hematologic cancer	0.00214	0.00483	CbGbCtD
Eplerenone—CYP3A4—Etoposide—hematologic cancer	0.00196	0.00442	CbGbCtD
Eplerenone—CYP3A4—Dexamethasone—hematologic cancer	0.00161	0.00364	CbGbCtD
Eplerenone—CYP3A4—Doxorubicin—hematologic cancer	0.00134	0.00302	CbGbCtD
Eplerenone—CYP11B2—hematopoietic system—hematologic cancer	0.00114	0.233	CbGeAlD
Eplerenone—CYP11B2—blood—hematologic cancer	0.000757	0.154	CbGeAlD
Eplerenone—NR3C2—hematopoietic system—hematologic cancer	0.000504	0.103	CbGeAlD
Eplerenone—CYP11B2—lymph node—hematologic cancer	0.000454	0.0924	CbGeAlD
Eplerenone—NR3C2—blood—hematologic cancer	0.000334	0.068	CbGeAlD
Eplerenone—NR3C2—lung—hematologic cancer	0.000293	0.0596	CbGeAlD
Eplerenone—NR3C2—testis—hematologic cancer	0.000276	0.0563	CbGeAlD
Eplerenone—CYP3A5—hematopoietic system—hematologic cancer	0.000272	0.0555	CbGeAlD
Eplerenone—Testosterone Propionate—UGT1A1—hematologic cancer	0.000253	0.0749	CrCbGaD
Eplerenone—Drospirenone—AR—hematologic cancer	0.000216	0.0638	CrCbGaD
Eplerenone—CYP3A4—hematopoietic system—hematologic cancer	0.000204	0.0416	CbGeAlD
Eplerenone—Fludrocortisone—AR—hematologic cancer	0.000203	0.06	CrCbGaD
Eplerenone—NR3C2—lymph node—hematologic cancer	0.0002	0.0408	CbGeAlD
Eplerenone—Testosterone Propionate—AR—hematologic cancer	0.000181	0.0535	CrCbGaD
Eplerenone—CYP3A5—blood—hematologic cancer	0.000181	0.0368	CbGeAlD
Eplerenone—Hydrocortamate—NR3C1—hematologic cancer	0.000177	0.0522	CrCbGaD
Eplerenone—Cortisone acetate—NR3C1—hematologic cancer	0.000174	0.0514	CrCbGaD
Eplerenone—Fluoxymesterone—AR—hematologic cancer	0.000168	0.0496	CrCbGaD
Eplerenone—CYP3A5—lung—hematologic cancer	0.000158	0.0322	CbGeAlD
Eplerenone—Spironolactone—AR—hematologic cancer	0.000154	0.0454	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—AR—hematologic cancer	0.000144	0.0425	CrCbGaD
Eplerenone—Fludrocortisone—NR3C1—hematologic cancer	0.000138	0.0407	CrCbGaD
Eplerenone—Methyltestosterone—AR—hematologic cancer	0.000136	0.04	CrCbGaD
Eplerenone—CYP3A4—blood—hematologic cancer	0.000135	0.0276	CbGeAlD
Eplerenone—Fluoxymesterone—ESR1—hematologic cancer	0.000129	0.0382	CrCbGaD
Eplerenone—Fluoxymesterone—NR3C1—hematologic cancer	0.000114	0.0336	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	0.000111	0.0328	CrCbGaD
Eplerenone—Spironolactone—NR3C1—hematologic cancer	0.000104	0.0308	CrCbGaD
Eplerenone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	9.77e-05	0.0289	CrCbGaD
Eplerenone—Progesterone—SLC22A1—hematologic cancer	9.36e-05	0.0277	CrCbGaD
Eplerenone—Testosterone—SLC22A1—hematologic cancer	8.85e-05	0.0261	CrCbGaD
Eplerenone—Progesterone—AR—hematologic cancer	8.32e-05	0.0246	CrCbGaD
Eplerenone—Hydrocortisone—ABCG2—hematologic cancer	8.03e-05	0.0237	CrCbGaD
Eplerenone—Testosterone—AR—hematologic cancer	7.86e-05	0.0232	CrCbGaD
Eplerenone—Hydrocortisone—NR3C1—hematologic cancer	6.92e-05	0.0205	CrCbGaD
Eplerenone—Progesterone—ESR1—hematologic cancer	6.41e-05	0.0189	CrCbGaD
Eplerenone—Testosterone—ABCG2—hematologic cancer	6.18e-05	0.0183	CrCbGaD
Eplerenone—Progesterone—NR3C1—hematologic cancer	5.64e-05	0.0167	CrCbGaD
Eplerenone—Spironolactone—ABCB1—hematologic cancer	5.03e-05	0.0149	CrCbGaD
Eplerenone—Methyltestosterone—ALB—hematologic cancer	4.65e-05	0.0137	CrCbGaD
Eplerenone—Hydrocortisone—ABCB1—hematologic cancer	3.34e-05	0.00987	CrCbGaD
Eplerenone—Progesterone—ABCB1—hematologic cancer	2.72e-05	0.00804	CrCbGaD
Eplerenone—Testosterone—ALB—hematologic cancer	2.7e-05	0.00797	CrCbGaD
Eplerenone—Testosterone—ABCB1—hematologic cancer	2.57e-05	0.0076	CrCbGaD
Eplerenone—Nausea—Alitretinoin—hematologic cancer	2.39e-05	0.000133	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—hematologic cancer	2.38e-05	0.000133	CcSEcCtD
Eplerenone—Rash—Irinotecan—hematologic cancer	2.38e-05	0.000132	CcSEcCtD
Eplerenone—Rash—Mitoxantrone—hematologic cancer	2.38e-05	0.000132	CcSEcCtD
Eplerenone—Dermatitis—Mitoxantrone—hematologic cancer	2.38e-05	0.000132	CcSEcCtD
Eplerenone—Dermatitis—Irinotecan—hematologic cancer	2.38e-05	0.000132	CcSEcCtD
Eplerenone—Headache—Mitoxantrone—hematologic cancer	2.36e-05	0.000131	CcSEcCtD
Eplerenone—Headache—Irinotecan—hematologic cancer	2.36e-05	0.000131	CcSEcCtD
Eplerenone—Nausea—Ifosfamide—hematologic cancer	2.36e-05	0.000131	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.35e-05	0.000131	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.35e-05	0.000131	CcSEcCtD
Eplerenone—Myalgia—Prednisone—hematologic cancer	2.35e-05	0.00013	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—hematologic cancer	2.35e-05	0.00013	CcSEcCtD
Eplerenone—Feeling abnormal—Triamcinolone—hematologic cancer	2.35e-05	0.00013	CcSEcCtD
Eplerenone—Diarrhoea—Cisplatin—hematologic cancer	2.34e-05	0.00013	CcSEcCtD
Eplerenone—Vomiting—Gemcitabine—hematologic cancer	2.34e-05	0.00013	CcSEcCtD
Eplerenone—Insomnia—Dexamethasone—hematologic cancer	2.34e-05	0.00013	CcSEcCtD
Eplerenone—Insomnia—Betamethasone—hematologic cancer	2.34e-05	0.00013	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.33e-05	0.00013	CcSEcCtD
Eplerenone—Discomfort—Prednisone—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Eplerenone—Rash—Gemcitabine—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Eplerenone—Dermatitis—Gemcitabine—hematologic cancer	2.32e-05	0.000129	CcSEcCtD
Eplerenone—Tinnitus—Epirubicin—hematologic cancer	2.31e-05	0.000128	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Eplerenone—Headache—Gemcitabine—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Eplerenone—Nausea—Vincristine—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Eplerenone—Flushing—Epirubicin—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Eplerenone—Cardiac disorder—Epirubicin—hematologic cancer	2.3e-05	0.000128	CcSEcCtD
Eplerenone—Hypoaesthesia—Doxorubicin—hematologic cancer	2.28e-05	0.000127	CcSEcCtD
Eplerenone—Pharyngitis—Doxorubicin—hematologic cancer	2.27e-05	0.000126	CcSEcCtD
Eplerenone—Dyspepsia—Dexamethasone—hematologic cancer	2.27e-05	0.000126	CcSEcCtD
Eplerenone—Dyspepsia—Betamethasone—hematologic cancer	2.27e-05	0.000126	CcSEcCtD
Eplerenone—Urinary tract disorder—Doxorubicin—hematologic cancer	2.26e-05	0.000126	CcSEcCtD
Eplerenone—Oedema peripheral—Doxorubicin—hematologic cancer	2.26e-05	0.000126	CcSEcCtD
Eplerenone—Asthenia—Etoposide—hematologic cancer	2.25e-05	0.000125	CcSEcCtD
Eplerenone—Connective tissue disorder—Doxorubicin—hematologic cancer	2.25e-05	0.000125	CcSEcCtD
Eplerenone—Body temperature increased—Triamcinolone—hematologic cancer	2.25e-05	0.000125	CcSEcCtD
Eplerenone—Angiopathy—Epirubicin—hematologic cancer	2.25e-05	0.000125	CcSEcCtD
Eplerenone—Urethral disorder—Doxorubicin—hematologic cancer	2.25e-05	0.000125	CcSEcCtD
Eplerenone—Nausea—Mitoxantrone—hematologic cancer	2.24e-05	0.000125	CcSEcCtD
Eplerenone—Nausea—Irinotecan—hematologic cancer	2.24e-05	0.000125	CcSEcCtD
Eplerenone—Infection—Prednisone—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Mediastinal disorder—Epirubicin—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Back pain—Methotrexate—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Fatigue—Betamethasone—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Fatigue—Dexamethasone—hematologic cancer	2.23e-05	0.000124	CcSEcCtD
Eplerenone—Pruritus—Etoposide—hematologic cancer	2.22e-05	0.000123	CcSEcCtD
Eplerenone—Shock—Prednisone—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—PARP1—hematologic cancer	2.21e-05	0.00118	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NCOR2—hematologic cancer	2.21e-05	0.00118	CbGpPWpGaD
Eplerenone—Pain—Dexamethasone—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Eplerenone—Pain—Betamethasone—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—hematologic cancer	2.21e-05	0.000123	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—hematologic cancer	2.18e-05	0.000121	CcSEcCtD
Eplerenone—Nausea—Gemcitabine—hematologic cancer	2.18e-05	0.000121	CcSEcCtD
Eplerenone—Vomiting—Cisplatin—hematologic cancer	2.18e-05	0.000121	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Eplerenone—Mental disorder—Epirubicin—hematologic cancer	2.17e-05	0.000121	CcSEcCtD
Eplerenone—Rash—Cisplatin—hematologic cancer	2.16e-05	0.00012	CcSEcCtD
Eplerenone—Dermatitis—Cisplatin—hematologic cancer	2.16e-05	0.00012	CcSEcCtD
Eplerenone—Malnutrition—Epirubicin—hematologic cancer	2.16e-05	0.00012	CcSEcCtD
Eplerenone—Diarrhoea—Etoposide—hematologic cancer	2.15e-05	0.000119	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—hematologic cancer	2.14e-05	0.000119	CcSEcCtD
Eplerenone—Tinnitus—Doxorubicin—hematologic cancer	2.14e-05	0.000119	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—HDAC2—hematologic cancer	2.13e-05	0.00114	CbGpPWpGaD
Eplerenone—Anaemia—Methotrexate—hematologic cancer	2.13e-05	0.000118	CcSEcCtD
Eplerenone—Feeling abnormal—Betamethasone—hematologic cancer	2.13e-05	0.000118	CcSEcCtD
Eplerenone—Feeling abnormal—Dexamethasone—hematologic cancer	2.13e-05	0.000118	CcSEcCtD
Eplerenone—Flushing—Doxorubicin—hematologic cancer	2.13e-05	0.000118	CcSEcCtD
Eplerenone—Cardiac disorder—Doxorubicin—hematologic cancer	2.13e-05	0.000118	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—FTCD—hematologic cancer	2.13e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GMPS—hematologic cancer	2.13e-05	0.00114	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PHYH—hematologic cancer	2.13e-05	0.00114	CbGpPWpGaD
Eplerenone—Flatulence—Epirubicin—hematologic cancer	2.12e-05	0.000118	CcSEcCtD
Eplerenone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.11e-05	0.000117	CcSEcCtD
Eplerenone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.11e-05	0.000117	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—IDH1—hematologic cancer	2.1e-05	0.00113	CbGpPWpGaD
Eplerenone—Back pain—Epirubicin—hematologic cancer	2.08e-05	0.000116	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—TXN—hematologic cancer	2.08e-05	0.00111	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ABCC3—hematologic cancer	2.08e-05	0.00111	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTO1—hematologic cancer	2.08e-05	0.00111	CbGpPWpGaD
Eplerenone—Angiopathy—Doxorubicin—hematologic cancer	2.08e-05	0.000116	CcSEcCtD
Eplerenone—Malaise—Methotrexate—hematologic cancer	2.08e-05	0.000116	CcSEcCtD
Eplerenone—Dizziness—Etoposide—hematologic cancer	2.08e-05	0.000115	CcSEcCtD
Eplerenone—Muscle spasms—Epirubicin—hematologic cancer	2.07e-05	0.000115	CcSEcCtD
Eplerenone—Mediastinal disorder—Doxorubicin—hematologic cancer	2.06e-05	0.000115	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.05e-05	0.000114	CcSEcCtD
Eplerenone—Dizziness—Prednisolone—hematologic cancer	2.05e-05	0.000114	CcSEcCtD
Eplerenone—Asthenia—Triamcinolone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Eplerenone—Body temperature increased—Dexamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Eplerenone—Abdominal pain—Dexamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Eplerenone—Abdominal pain—Betamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Eplerenone—Body temperature increased—Betamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—SPHK1—hematologic cancer	2.04e-05	0.00109	CbGpPWpGaD
Eplerenone—Nausea—Cisplatin—hematologic cancer	2.03e-05	0.000113	CcSEcCtD
Eplerenone—Insomnia—Prednisone—hematologic cancer	2.03e-05	0.000113	CcSEcCtD
Eplerenone—Pruritus—Triamcinolone—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Eplerenone—Cough—Methotrexate—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Eplerenone—Mental disorder—Doxorubicin—hematologic cancer	2.01e-05	0.000112	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTP1—hematologic cancer	2.01e-05	0.00107	CbGpPWpGaD
Eplerenone—Ill-defined disorder—Epirubicin—hematologic cancer	2e-05	0.000111	CcSEcCtD
Eplerenone—Vomiting—Etoposide—hematologic cancer	2e-05	0.000111	CcSEcCtD
Eplerenone—Malnutrition—Doxorubicin—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Eplerenone—Anaemia—Epirubicin—hematologic cancer	1.99e-05	0.000111	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—hematologic cancer	1.98e-05	0.00011	CcSEcCtD
Eplerenone—Rash—Etoposide—hematologic cancer	1.98e-05	0.00011	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTP1—hematologic cancer	1.98e-05	0.00106	CbGpPWpGaD
Eplerenone—Dermatitis—Etoposide—hematologic cancer	1.98e-05	0.00011	CcSEcCtD
Eplerenone—Headache—Etoposide—hematologic cancer	1.97e-05	0.000109	CcSEcCtD
Eplerenone—Flatulence—Doxorubicin—hematologic cancer	1.97e-05	0.000109	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—hematologic cancer	1.96e-05	0.000109	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—hematologic cancer	1.96e-05	0.000109	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—hematologic cancer	1.96e-05	0.000109	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—UGT1A1—hematologic cancer	1.96e-05	0.00105	CbGpPWpGaD
Eplerenone—Rash—Prednisolone—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Eplerenone—Dermatitis—Prednisolone—hematologic cancer	1.95e-05	0.000108	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.95e-05	0.000108	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—SMPD3—hematologic cancer	1.94e-05	0.00104	CbGpPWpGaD
Eplerenone—Malaise—Epirubicin—hematologic cancer	1.94e-05	0.000108	CcSEcCtD
Eplerenone—Fatigue—Prednisone—hematologic cancer	1.94e-05	0.000108	CcSEcCtD
Eplerenone—Headache—Prednisolone—hematologic cancer	1.94e-05	0.000108	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—hematologic cancer	1.94e-05	0.000108	CcSEcCtD
Eplerenone—Syncope—Epirubicin—hematologic cancer	1.93e-05	0.000107	CcSEcCtD
Eplerenone—Back pain—Doxorubicin—hematologic cancer	1.93e-05	0.000107	CcSEcCtD
Eplerenone—Constipation—Prednisone—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Eplerenone—Muscle spasms—Doxorubicin—hematologic cancer	1.92e-05	0.000107	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CRABP1—hematologic cancer	1.9e-05	0.00102	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—SLC22A1—hematologic cancer	1.9e-05	0.00102	CbGpPWpGaD
Eplerenone—Loss of consciousness—Epirubicin—hematologic cancer	1.89e-05	0.000105	CcSEcCtD
Eplerenone—Dizziness—Triamcinolone—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Eplerenone—Cough—Epirubicin—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Eplerenone—Infection—Methotrexate—hematologic cancer	1.87e-05	0.000104	CcSEcCtD
Eplerenone—Nausea—Etoposide—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ALOX5—hematologic cancer	1.86e-05	0.000992	CbGpPWpGaD
Eplerenone—Feeling abnormal—Prednisone—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Eplerenone—Asthenia—Dexamethasone—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Eplerenone—Asthenia—Betamethasone—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Eplerenone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000103	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—AR—hematologic cancer	1.85e-05	0.000989	CbGpPWpGaD
Eplerenone—Nervous system disorder—Methotrexate—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Eplerenone—Anaemia—Doxorubicin—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—GSTM1—hematologic cancer	1.84e-05	0.000985	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Prednisone—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Eplerenone—Nausea—Prednisolone—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Eplerenone—Arthralgia—Epirubicin—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Eplerenone—Chest pain—Epirubicin—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Eplerenone—Myalgia—Epirubicin—hematologic cancer	1.84e-05	0.000102	CcSEcCtD
Eplerenone—Pruritus—Dexamethasone—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Eplerenone—Pruritus—Betamethasone—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—hematologic cancer	1.83e-05	0.000102	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Eplerenone—CYP3A5—Metapathway biotransformation—GSTM1—hematologic cancer	1.82e-05	0.000972	CbGpPWpGaD
Eplerenone—Hyperhidrosis—Methotrexate—hematologic cancer	1.82e-05	0.000101	CcSEcCtD
Eplerenone—Discomfort—Epirubicin—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Eplerenone—Vomiting—Triamcinolone—hematologic cancer	1.81e-05	0.000101	CcSEcCtD
Eplerenone—Malaise—Doxorubicin—hematologic cancer	1.8e-05	0.0001	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—NUP98—hematologic cancer	1.8e-05	0.000961	CbGpPWpGaD
Eplerenone—Rash—Triamcinolone—hematologic cancer	1.79e-05	9.98e-05	CcSEcCtD
Eplerenone—Dermatitis—Triamcinolone—hematologic cancer	1.79e-05	9.97e-05	CcSEcCtD
Eplerenone—Syncope—Doxorubicin—hematologic cancer	1.79e-05	9.95e-05	CcSEcCtD
Eplerenone—Headache—Triamcinolone—hematologic cancer	1.78e-05	9.92e-05	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—hematologic cancer	1.78e-05	9.89e-05	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—hematologic cancer	1.78e-05	9.89e-05	CcSEcCtD
Eplerenone—Diarrhoea—Betamethasone—hematologic cancer	1.77e-05	9.83e-05	CcSEcCtD
Eplerenone—Diarrhoea—Dexamethasone—hematologic cancer	1.77e-05	9.83e-05	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—hematologic cancer	1.76e-05	9.77e-05	CcSEcCtD
Eplerenone—Loss of consciousness—Doxorubicin—hematologic cancer	1.75e-05	9.75e-05	CcSEcCtD
Eplerenone—Infection—Epirubicin—hematologic cancer	1.75e-05	9.72e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ADCY7—hematologic cancer	1.74e-05	0.000932	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NCOA3—hematologic cancer	1.74e-05	0.000932	CbGpPWpGaD
Eplerenone—Cough—Doxorubicin—hematologic cancer	1.74e-05	9.68e-05	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	1.73e-05	0.000927	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NUP214—hematologic cancer	1.73e-05	0.000926	CbGpPWpGaD
Eplerenone—Shock—Epirubicin—hematologic cancer	1.73e-05	9.62e-05	CcSEcCtD
Eplerenone—Nervous system disorder—Epirubicin—hematologic cancer	1.73e-05	9.59e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.71e-05	0.000916	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.71e-05	9.52e-05	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	1.71e-05	0.000915	CbGpPWpGaD
Eplerenone—Skin disorder—Epirubicin—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Eplerenone—Dizziness—Betamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Eplerenone—Dizziness—Dexamethasone—hematologic cancer	1.71e-05	9.5e-05	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CDKN2B—hematologic cancer	1.7e-05	0.000911	CbGpPWpGaD
Eplerenone—Hyperhidrosis—Epirubicin—hematologic cancer	1.7e-05	9.46e-05	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—hematologic cancer	1.7e-05	9.45e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—ASNS—hematologic cancer	1.7e-05	0.000909	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—B3GAT1—hematologic cancer	1.7e-05	0.000909	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—DCK—hematologic cancer	1.7e-05	0.000909	CbGpPWpGaD
Eplerenone—Myalgia—Doxorubicin—hematologic cancer	1.7e-05	9.44e-05	CcSEcCtD
Eplerenone—Chest pain—Doxorubicin—hematologic cancer	1.7e-05	9.44e-05	CcSEcCtD
Eplerenone—Arthralgia—Doxorubicin—hematologic cancer	1.7e-05	9.44e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—MTR—hematologic cancer	1.7e-05	0.000907	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ABCG2—hematologic cancer	1.7e-05	0.000907	CbGpPWpGaD
Eplerenone—Nausea—Triamcinolone—hematologic cancer	1.69e-05	9.4e-05	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.69e-05	9.38e-05	CcSEcCtD
Eplerenone—Discomfort—Doxorubicin—hematologic cancer	1.68e-05	9.33e-05	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—hematologic cancer	1.68e-05	9.32e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ENO2—hematologic cancer	1.66e-05	0.00089	CbGpPWpGaD
Eplerenone—Dyspepsia—Methotrexate—hematologic cancer	1.65e-05	9.2e-05	CcSEcCtD
Eplerenone—Hypotension—Epirubicin—hematologic cancer	1.64e-05	9.14e-05	CcSEcCtD
Eplerenone—Vomiting—Betamethasone—hematologic cancer	1.64e-05	9.13e-05	CcSEcCtD
Eplerenone—Vomiting—Dexamethasone—hematologic cancer	1.64e-05	9.13e-05	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	1.63e-05	0.000872	CbGpPWpGaD
Eplerenone—Rash—Dexamethasone—hematologic cancer	1.63e-05	9.06e-05	CcSEcCtD
Eplerenone—Rash—Betamethasone—hematologic cancer	1.63e-05	9.06e-05	CcSEcCtD
Eplerenone—Dermatitis—Dexamethasone—hematologic cancer	1.63e-05	9.05e-05	CcSEcCtD
Eplerenone—Dermatitis—Betamethasone—hematologic cancer	1.63e-05	9.05e-05	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.62e-05	9.02e-05	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—hematologic cancer	1.62e-05	9.01e-05	CcSEcCtD
Eplerenone—Headache—Dexamethasone—hematologic cancer	1.62e-05	9e-05	CcSEcCtD
Eplerenone—Headache—Betamethasone—hematologic cancer	1.62e-05	9e-05	CcSEcCtD
Eplerenone—Infection—Doxorubicin—hematologic cancer	1.62e-05	8.99e-05	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NCOR1—hematologic cancer	1.62e-05	0.000864	CbGpPWpGaD
Eplerenone—Asthenia—Prednisone—hematologic cancer	1.61e-05	8.97e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—GSTT1—hematologic cancer	1.61e-05	0.000863	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HDC—hematologic cancer	1.61e-05	0.000861	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	1.61e-05	0.00086	CbGpPWpGaD
Eplerenone—Pain—Methotrexate—hematologic cancer	1.61e-05	8.94e-05	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.6e-05	8.91e-05	CcSEcCtD
Eplerenone—Shock—Doxorubicin—hematologic cancer	1.6e-05	8.91e-05	CcSEcCtD
Eplerenone—Nervous system disorder—Doxorubicin—hematologic cancer	1.6e-05	8.88e-05	CcSEcCtD
Eplerenone—Pruritus—Prednisone—hematologic cancer	1.59e-05	8.85e-05	CcSEcCtD
Eplerenone—Insomnia—Epirubicin—hematologic cancer	1.59e-05	8.85e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.59e-05	0.00085	CbGpPWpGaD
Eplerenone—Skin disorder—Doxorubicin—hematologic cancer	1.58e-05	8.79e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—SDC1—hematologic cancer	1.58e-05	0.000843	CbGpPWpGaD
Eplerenone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.57e-05	8.75e-05	CcSEcCtD
Eplerenone—Dyspnoea—Epirubicin—hematologic cancer	1.57e-05	8.72e-05	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—hematologic cancer	1.55e-05	8.61e-05	CcSEcCtD
Eplerenone—Dyspepsia—Epirubicin—hematologic cancer	1.55e-05	8.61e-05	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—hematologic cancer	1.54e-05	8.56e-05	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.54e-05	8.55e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—PHYH—hematologic cancer	1.54e-05	0.000821	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GMPS—hematologic cancer	1.54e-05	0.000821	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—FTCD—hematologic cancer	1.54e-05	0.000821	CbGpPWpGaD
Eplerenone—Nausea—Dexamethasone—hematologic cancer	1.53e-05	8.53e-05	CcSEcCtD
Eplerenone—Nausea—Betamethasone—hematologic cancer	1.53e-05	8.53e-05	CcSEcCtD
Eplerenone—Hypotension—Doxorubicin—hematologic cancer	1.52e-05	8.46e-05	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.52e-05	8.45e-05	CcSEcCtD
Eplerenone—Fatigue—Epirubicin—hematologic cancer	1.52e-05	8.43e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.51e-05	0.000806	CbGpPWpGaD
Eplerenone—Pain—Epirubicin—hematologic cancer	1.5e-05	8.37e-05	CcSEcCtD
Eplerenone—Constipation—Epirubicin—hematologic cancer	1.5e-05	8.37e-05	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—NR3C1—hematologic cancer	1.5e-05	0.0008	CbGpPWpGaD
Eplerenone—Dizziness—Prednisone—hematologic cancer	1.49e-05	8.27e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.49e-05	0.000795	CbGpPWpGaD
Eplerenone—Body temperature increased—Methotrexate—hematologic cancer	1.49e-05	8.26e-05	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—hematologic cancer	1.49e-05	8.26e-05	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.48e-05	8.25e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—CDA—hematologic cancer	1.47e-05	0.000788	CbGpPWpGaD
Eplerenone—Insomnia—Doxorubicin—hematologic cancer	1.47e-05	8.19e-05	CcSEcCtD
Eplerenone—Dyspnoea—Doxorubicin—hematologic cancer	1.45e-05	8.07e-05	CcSEcCtD
Eplerenone—Feeling abnormal—Epirubicin—hematologic cancer	1.45e-05	8.06e-05	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.44e-05	0.000769	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.44e-05	8e-05	CcSEcCtD
Eplerenone—Dyspepsia—Doxorubicin—hematologic cancer	1.43e-05	7.97e-05	CcSEcCtD
Eplerenone—Vomiting—Prednisone—hematologic cancer	1.43e-05	7.95e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.42e-05	0.000761	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PC—hematologic cancer	1.42e-05	0.000758	CbGpPWpGaD
Eplerenone—Rash—Prednisone—hematologic cancer	1.42e-05	7.89e-05	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—hematologic cancer	1.42e-05	7.88e-05	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.41e-05	0.000756	CbGpPWpGaD
Eplerenone—Headache—Prednisone—hematologic cancer	1.41e-05	7.84e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—SMPD3—hematologic cancer	1.41e-05	0.000751	CbGpPWpGaD
Eplerenone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.41e-05	7.81e-05	CcSEcCtD
Eplerenone—Fatigue—Doxorubicin—hematologic cancer	1.4e-05	7.8e-05	CcSEcCtD
Eplerenone—Constipation—Doxorubicin—hematologic cancer	1.39e-05	7.74e-05	CcSEcCtD
Eplerenone—Pain—Doxorubicin—hematologic cancer	1.39e-05	7.74e-05	CcSEcCtD
Eplerenone—Abdominal pain—Epirubicin—hematologic cancer	1.39e-05	7.73e-05	CcSEcCtD
Eplerenone—Body temperature increased—Epirubicin—hematologic cancer	1.39e-05	7.73e-05	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—MYC—hematologic cancer	1.37e-05	0.000734	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GBA—hematologic cancer	1.37e-05	0.000732	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC35B2—hematologic cancer	1.37e-05	0.000732	CbGpPWpGaD
Eplerenone—Asthenia—Methotrexate—hematologic cancer	1.35e-05	7.5e-05	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.34e-05	0.000719	CbGpPWpGaD
Eplerenone—Feeling abnormal—Doxorubicin—hematologic cancer	1.34e-05	7.46e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—NQO1—hematologic cancer	1.34e-05	0.000717	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CD44—hematologic cancer	1.34e-05	0.000717	CbGpPWpGaD
Eplerenone—Nausea—Prednisone—hematologic cancer	1.34e-05	7.43e-05	CcSEcCtD
Eplerenone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.33e-05	7.4e-05	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—hematologic cancer	1.33e-05	7.4e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.31e-05	0.000702	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MAPK14—hematologic cancer	1.29e-05	0.000692	CbGpPWpGaD
Eplerenone—Body temperature increased—Doxorubicin—hematologic cancer	1.29e-05	7.16e-05	CcSEcCtD
Eplerenone—Abdominal pain—Doxorubicin—hematologic cancer	1.29e-05	7.16e-05	CcSEcCtD
Eplerenone—Diarrhoea—Methotrexate—hematologic cancer	1.29e-05	7.15e-05	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—ESR1—hematologic cancer	1.27e-05	0.000679	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYCS—hematologic cancer	1.27e-05	0.000678	CbGpPWpGaD
Eplerenone—Asthenia—Epirubicin—hematologic cancer	1.26e-05	7.02e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—HSP90AA1—hematologic cancer	1.26e-05	0.000674	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTAP—hematologic cancer	1.25e-05	0.00067	CbGpPWpGaD
Eplerenone—Pruritus—Epirubicin—hematologic cancer	1.24e-05	6.92e-05	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—hematologic cancer	1.24e-05	6.91e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—B3GAT1—hematologic cancer	1.23e-05	0.000657	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ASNS—hematologic cancer	1.23e-05	0.000657	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—DCK—hematologic cancer	1.23e-05	0.000657	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—NOTCH1—hematologic cancer	1.23e-05	0.000656	CbGpPWpGaD
Eplerenone—Diarrhoea—Epirubicin—hematologic cancer	1.2e-05	6.69e-05	CcSEcCtD
Eplerenone—Vomiting—Methotrexate—hematologic cancer	1.2e-05	6.65e-05	CcSEcCtD
Eplerenone—Rash—Methotrexate—hematologic cancer	1.19e-05	6.59e-05	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—hematologic cancer	1.18e-05	6.58e-05	CcSEcCtD
Eplerenone—Headache—Methotrexate—hematologic cancer	1.18e-05	6.55e-05	CcSEcCtD
Eplerenone—Asthenia—Doxorubicin—hematologic cancer	1.17e-05	6.49e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—HDC—hematologic cancer	1.16e-05	0.000623	CbGpPWpGaD
Eplerenone—Dizziness—Epirubicin—hematologic cancer	1.16e-05	6.47e-05	CcSEcCtD
Eplerenone—Pruritus—Doxorubicin—hematologic cancer	1.15e-05	6.4e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.13e-05	0.000607	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GSTP1—hematologic cancer	1.12e-05	0.000598	CbGpPWpGaD
Eplerenone—Vomiting—Epirubicin—hematologic cancer	1.12e-05	6.22e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—FHL2—hematologic cancer	1.12e-05	0.000597	CbGpPWpGaD
Eplerenone—Nausea—Methotrexate—hematologic cancer	1.12e-05	6.21e-05	CcSEcCtD
Eplerenone—Diarrhoea—Doxorubicin—hematologic cancer	1.11e-05	6.19e-05	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CREBBP—hematologic cancer	1.11e-05	0.000595	CbGpPWpGaD
Eplerenone—Rash—Epirubicin—hematologic cancer	1.11e-05	6.17e-05	CcSEcCtD
Eplerenone—Dermatitis—Epirubicin—hematologic cancer	1.11e-05	6.16e-05	CcSEcCtD
Eplerenone—Headache—Epirubicin—hematologic cancer	1.1e-05	6.13e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—AGRN—hematologic cancer	1.09e-05	0.000585	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.08e-05	0.000579	CbGpPWpGaD
Eplerenone—Dizziness—Doxorubicin—hematologic cancer	1.08e-05	5.99e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—CDA—hematologic cancer	1.06e-05	0.000569	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ABCB1—hematologic cancer	1.06e-05	0.000566	CbGpPWpGaD
Eplerenone—Nausea—Epirubicin—hematologic cancer	1.04e-05	5.81e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—HMMR—hematologic cancer	1.04e-05	0.000555	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—IDH2—hematologic cancer	1.04e-05	0.000555	CbGpPWpGaD
Eplerenone—Vomiting—Doxorubicin—hematologic cancer	1.03e-05	5.76e-05	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—GSTM1—hematologic cancer	1.03e-05	0.00055	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NCOR1—hematologic cancer	1.03e-05	0.00055	CbGpPWpGaD
Eplerenone—Rash—Doxorubicin—hematologic cancer	1.03e-05	5.71e-05	CcSEcCtD
Eplerenone—Dermatitis—Doxorubicin—hematologic cancer	1.03e-05	5.7e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—PC—hematologic cancer	1.03e-05	0.000548	CbGpPWpGaD
Eplerenone—Headache—Doxorubicin—hematologic cancer	1.02e-05	5.67e-05	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—GBA—hematologic cancer	9.9e-06	0.000529	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC35B2—hematologic cancer	9.9e-06	0.000529	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ARNTL—hematologic cancer	9.76e-06	0.000522	CbGpPWpGaD
Eplerenone—Nausea—Doxorubicin—hematologic cancer	9.67e-06	5.38e-05	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—ACP5—hematologic cancer	9.49e-06	0.000508	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CA9—hematologic cancer	9.49e-06	0.000508	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOR2—hematologic cancer	9.37e-06	0.000501	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	9.32e-06	0.000498	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	9.19e-06	0.000492	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MTHFR—hematologic cancer	9.08e-06	0.000486	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTAP—hematologic cancer	9.06e-06	0.000484	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—IDH1—hematologic cancer	8.93e-06	0.000477	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ABCC3—hematologic cancer	8.83e-06	0.000472	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTO1—hematologic cancer	8.83e-06	0.000472	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—TXN—hematologic cancer	8.83e-06	0.000472	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SPHK1—hematologic cancer	8.64e-06	0.000462	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	8.57e-06	0.000458	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	8.45e-06	0.000452	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—UGT1A1—hematologic cancer	8.3e-06	0.000444	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SLC22A1—hematologic cancer	8.07e-06	0.000432	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CRABP1—hematologic cancer	8.07e-06	0.000432	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—FHL2—hematologic cancer	8.07e-06	0.000432	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.01e-06	0.000428	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AGRN—hematologic cancer	7.92e-06	0.000423	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALOX5—hematologic cancer	7.87e-06	0.000421	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CG—hematologic cancer	7.63e-06	0.000408	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NUP98—hematologic cancer	7.62e-06	0.000407	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—IDH2—hematologic cancer	7.5e-06	0.000401	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HMMR—hematologic cancer	7.5e-06	0.000401	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADCY7—hematologic cancer	7.4e-06	0.000395	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOA3—hematologic cancer	7.4e-06	0.000395	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NUP214—hematologic cancer	7.34e-06	0.000393	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ABCG2—hematologic cancer	7.2e-06	0.000385	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTR—hematologic cancer	7.2e-06	0.000385	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PHYH—hematologic cancer	7.14e-06	0.000382	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GMPS—hematologic cancer	7.14e-06	0.000382	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—FTCD—hematologic cancer	7.14e-06	0.000382	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CREBBP—hematologic cancer	7.08e-06	0.000378	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ENO2—hematologic cancer	7.06e-06	0.000377	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ARNTL—hematologic cancer	7.05e-06	0.000377	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CA9—hematologic cancer	6.86e-06	0.000367	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ACP5—hematologic cancer	6.86e-06	0.000367	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTT1—hematologic cancer	6.84e-06	0.000366	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MAPK3—hematologic cancer	6.79e-06	0.000363	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOR2—hematologic cancer	6.77e-06	0.000362	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CD—hematologic cancer	6.71e-06	0.000359	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—SDC1—hematologic cancer	6.69e-06	0.000358	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALB—hematologic cancer	6.62e-06	0.000354	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—MYC—hematologic cancer	6.61e-06	0.000353	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SMPD3—hematologic cancer	6.53e-06	0.000349	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—IDH1—hematologic cancer	6.45e-06	0.000345	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCC3—hematologic cancer	6.38e-06	0.000341	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTO1—hematologic cancer	6.38e-06	0.000341	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—TXN—hematologic cancer	6.38e-06	0.000341	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3R1—hematologic cancer	6.34e-06	0.000339	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SPHK1—hematologic cancer	6.24e-06	0.000334	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—UGT1A1—hematologic cancer	6e-06	0.000321	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CB—hematologic cancer	5.85e-06	0.000313	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SLC22A1—hematologic cancer	5.84e-06	0.000312	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CRABP1—hematologic cancer	5.84e-06	0.000312	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	5.71e-06	0.000305	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ASNS—hematologic cancer	5.71e-06	0.000305	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—DCK—hematologic cancer	5.71e-06	0.000305	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NQO1—hematologic cancer	5.69e-06	0.000304	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CD44—hematologic cancer	5.69e-06	0.000304	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALOX5—hematologic cancer	5.69e-06	0.000304	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NUP98—hematologic cancer	5.51e-06	0.000294	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HDC—hematologic cancer	5.41e-06	0.000289	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYCS—hematologic cancer	5.38e-06	0.000288	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	5.35e-06	0.000286	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADCY7—hematologic cancer	5.35e-06	0.000286	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOA3—hematologic cancer	5.35e-06	0.000286	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NUP214—hematologic cancer	5.31e-06	0.000284	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTR—hematologic cancer	5.2e-06	0.000278	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCG2—hematologic cancer	5.2e-06	0.000278	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ENO2—hematologic cancer	5.1e-06	0.000273	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PTEN—hematologic cancer	5.05e-06	0.00027	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CDA—hematologic cancer	4.95e-06	0.000265	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTT1—hematologic cancer	4.95e-06	0.000264	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—SDC1—hematologic cancer	4.84e-06	0.000259	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—hematologic cancer	4.82e-06	0.000258	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PC—hematologic cancer	4.77e-06	0.000255	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTP1—hematologic cancer	4.74e-06	0.000254	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GBA—hematologic cancer	4.6e-06	0.000246	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.6e-06	0.000246	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—AKT1—hematologic cancer	4.58e-06	0.000245	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ABCB1—hematologic cancer	4.49e-06	0.00024	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—NCOR1—hematologic cancer	4.36e-06	0.000233	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GSTM1—hematologic cancer	4.36e-06	0.000233	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTAP—hematologic cancer	4.21e-06	0.000225	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CD44—hematologic cancer	4.11e-06	0.00022	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NQO1—hematologic cancer	4.11e-06	0.00022	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYCS—hematologic cancer	3.89e-06	0.000208	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.87e-06	0.000207	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.85e-06	0.000206	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—FHL2—hematologic cancer	3.75e-06	0.000201	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AGRN—hematologic cancer	3.68e-06	0.000197	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PIK3CA—hematologic cancer	3.57e-06	0.000191	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HMMR—hematologic cancer	3.49e-06	0.000187	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—IDH2—hematologic cancer	3.49e-06	0.000187	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.43e-06	0.000183	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.28e-06	0.000175	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.25e-06	0.000174	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.24e-06	0.000173	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ACP5—hematologic cancer	3.19e-06	0.000171	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CA9—hematologic cancer	3.19e-06	0.000171	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.15e-06	0.000168	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.15e-06	0.000168	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.15e-06	0.000168	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CREBBP—hematologic cancer	3e-06	0.00016	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—IDH1—hematologic cancer	3e-06	0.00016	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.97e-06	0.000159	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—TXN—hematologic cancer	2.97e-06	0.000159	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.97e-06	0.000159	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—AKT1—hematologic cancer	2.91e-06	0.000156	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.9e-06	0.000155	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.85e-06	0.000152	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALB—hematologic cancer	2.81e-06	0.00015	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.79e-06	0.000149	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.78e-06	0.000149	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.71e-06	0.000145	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.71e-06	0.000145	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.69e-06	0.000144	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.64e-06	0.000141	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.56e-06	0.000137	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.49e-06	0.000133	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.49e-06	0.000133	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.48e-06	0.000133	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.47e-06	0.000132	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.42e-06	0.000129	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTR—hematologic cancer	2.42e-06	0.000129	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.37e-06	0.000127	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.34e-06	0.000125	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.3e-06	0.000123	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.25e-06	0.00012	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.17e-06	0.000116	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.14e-06	0.000115	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.06e-06	0.00011	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—hematologic cancer	2.04e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALB—hematologic cancer	2.03e-06	0.000109	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.94e-06	0.000104	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.91e-06	0.000102	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CD44—hematologic cancer	1.91e-06	0.000102	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.81e-06	9.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.8e-06	9.61e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.79e-06	9.59e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.59e-06	8.52e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.55e-06	8.28e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.51e-06	8.08e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.51e-06	8.07e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—hematologic cancer	1.48e-06	7.9e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.46e-06	7.83e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.46e-06	7.83e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.29e-06	6.92e-05	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.24e-06	6.6e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.09e-06	5.84e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.09e-06	5.82e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.01e-06	5.39e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.56e-07	5.11e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALB—hematologic cancer	9.44e-07	5.05e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.03e-07	4.83e-05	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—AKT1—hematologic cancer	8.93e-07	4.77e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.34e-07	4.46e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PTEN—hematologic cancer	7.2e-07	3.85e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—hematologic cancer	6.87e-07	3.67e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.08e-07	2.72e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—AKT1—hematologic cancer	4.15e-07	2.22e-05	CbGpPWpGaD
